NOVATURASNOVATURASNOVATURAS

NOVATURAS

No trades
See on Supercharts
Market capitalization
‪23.42 M‬EUR
‪3.69 M‬EUR
‪208.55 M‬EUR
‪4.20 M‬
Beta (1Y)
−0.12

About NOVATURAS

CEO
Vitalij Rakovski
Headquarters
Kaunas
Founded
1999
ISIN
LT0000131872
FIGI
BBG00KD9VRL4
Novaturas AB engages in the organization and provision of tourism services. It offers a full holiday experience to clients from the stage of planning to book flights, accommodation, transfers and activities during the stay, as well as round trips by coach and by plane. It operates through the following segments: Flight Packages, Sightseeing Tours by Plane, Sightseeing Tours by Coach, and Other. The company was founded on December 16, 1999 and is headquartered in Kaunas, Lithuania.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NTU1L is 3.00 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXVSE exchange NOVATURAS stocks are traded under the ticker NTU1L.
NTU1L stock is 0.33% volatile and has beta coefficient of −0.12. Check out the list of the most volatile stocks — is NOVATURAS there?
NOVATURAS revenue for the last quarter amounts to ‪64.30 M‬ EUR despite the estimated figure of ‪66.80 M‬ EUR. In the next quarter revenue is expected to reach ‪42.90 M‬ EUR.
Yes, you can track NOVATURAS financials in yearly and quarterly reports right on TradingView.
NTU1L stock has fallen by 3.23% compared to the previous week, the month change is a 8.26% fall, over the last year NOVATURAS has showed a 5.66% decrease.
NTU1L net income for the last quarter is ‪−2.68 M‬ EUR, while the quarter before that showed ‪1.62 M‬ EUR of net income which accounts for −265.25% change. Track more NOVATURAS financial stats to get the full picture.
Today NOVATURAS has the market capitalization of ‪23.25 M‬, it has decreased by 1.26% over the last week.
Like other stocks, NTU1L shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVATURAS stock right from TradingView charts — choose your broker and connect to your account.
NTU1L reached its all-time high on Jul 23, 2018 with the price of 12.78 EUR, and its all-time low was 1.76 EUR and was reached on Sep 29, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVATURAS technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVATURAS stock shows the sell signal. See more of NOVATURAS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVATURAS EBITDA is ‪5.22 M‬ EUR, and current EBITDA margin is 2.49%. See more stats in NOVATURAS financial statements.